Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I

  • Afsar Ali Mian1,
  • Anna Metodieva1,
  • Susanne Badura1,
  • Mamduh Khateb2,
  • Nili Ruimi2,
  • Yousef Najajreh3,
  • Oliver Gerhard Ottmann1,
  • Jamal Mahajna2, 4 and
  • Martin Ruthardt1, 5Email author
BMC Cancer201212:411

DOI: 10.1186/1471-2407-12-411

Received: 13 April 2012

Accepted: 31 August 2012

Published: 17 September 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
13 Apr 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
1 Jun 2012 Reviewed Reviewer Report - Oliver Hantschel
5 Jun 2012 Reviewed Reviewer Report - Seiichi Okabe
16 Jul 2012 Author responded Author comments - Martin Ruthardt
Resubmission - Version 3
16 Jul 2012 Submitted Manuscript version 3
1 Aug 2012 Reviewed Reviewer Report - Seiichi Okabe
23 Aug 2012 Author responded Author comments - Martin Ruthardt
Resubmission - Version 4
23 Aug 2012 Submitted Manuscript version 4
Publishing
31 Aug 2012 Editorially accepted
17 Sep 2012 Article published 10.1186/1471-2407-12-411

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Hematology, Goethe University
(2)
Cancer Drug Discovery, Migal-Galilee Technology Center
(3)
Faculty of Pharmacy, Al-Quds University
(4)
Departments of Nutritional Sciences, Tel Hai Academic College
(5)
Labor für Tumorstammzellbiologie, Med. Klinik II/Hämatologie, Klinikum der Goethe Universität Frankfurt

Advertisement